ADHD Medication Shortage
We are heading into the second year of experiencing a nationwide shortage of ADHD medications such as Vyvanse, Adderall, and their generic alternatives. Regardless of the cause, MedOne is committed to ensure members have access to an appropriate prescription at an affordable cost.
Formulary Change
Some brands like Vyvanse are excluded from the Performance Formulary due to the availability of generic alternatives. The MedOne Formulary Subcommittee meets weekly to evaluate market changes and adjust formularies as necessary. Recently, the Subcommittee discussed the shortage of ADHD medications and decided to adjust the Performance Formulary Exclusions. They evaluated the cost impact and the impact on clinical outcomes and member/client satisfaction and determined it was best to allow brand Vyvanse on formulary in a non-preferred tier until the generic becomes readily available.
What This Means For You
When you go to the pharmacy to fill your preferred generic ADHD medication, your pharmacy may not have it. There are two options:
Option 1
You can call MedOne and ask that they help source the prescribed generic at another nearby pharmacy or to see if other generics are available at your pharmacy.
Option 2
The pharmacy may dispense Vyvanse. However, please note that any brand medication that is dispensed is subject to any applicable brand copay.
If you have NOT previously been prescribed Vyvanse or a similar brand, you may be subject to Step Therapy and Prior Authorization requirements. You may be required to step through two (2) preferred generic long acting stimulants before the plan would allow a brand long-acting stimulant (Vyvanse or otherwise).
Please Note: DAW penalties will still apply. If you request a brand when a generic alternative is available, you will be required to pay both your brand copay PLUS the difference between the prescribed generic and the requested brand.
Please contact your MedOne Account Management Team for additional details.